Literature DB >> 10919887

Criteria for nonsurgical management of subperiosteal abscess of the orbit: analysis of outcomes 1988-1998.

G H Garcia1, G J Harris.   

Abstract

PURPOSE: On the basis of bacteriologic studies, we have recommended expectant observation with intravenous antibiotics for subperiosteal abscess (SPA) of the orbit in patients less than 9 years of age, given the absence of eight other specific surgical criteria. We attempted to test these recommendations with a prospective study. STUDY
DESIGN: Prospective noncomparative case series. PARTICIPANTS: Forty patients younger than 9 years of age treated for orbital SPAs at the Childrens Hospital of Wisconsin from 1988 to 1998.
METHODS: Specific management criteria were applied to a cohort of 37 orbital SPA patients. Three other orbital SPA patients under the age of 9, either ineligible for medical therapy or treated outside our guidelines, were also studied. Clinical data for all patients were reviewed and analyzed. MAIN OUTCOME MEASURES: Clinical resolution of the abscess, as evidenced by normal visual acuity, pupillary examination, motility, and globe position on the affected side.
RESULTS: Eight patients met criteria for surgical treatment and underwent prompt drainage. Of the 29 patients for whom initial nonsurgical management was recommended, 27 (93.1%) SPAs cleared with expectant observation on intravenous antibiotics, and 2 patients defaulted to surgical intervention. All cases had successful clinical outcomes.
CONCLUSIONS: In patients less than 9 years of age, orbital SPAs are likely to resolve without surgery, provided certain surgical criteria are absent.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10919887     DOI: 10.1016/s0161-6420(00)00242-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  22 in total

1.  Etiology, Diagnosis, and Treatment of Orbital Infections.

Authors:  Gary Schwartz
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

2.  Functional endoscopic sinus surgery: indications and complications in the ophthalmic field.

Authors:  Abdullah Al-Mujaini; Upender Wali; Mazin Alkhabori
Journal:  Oman Med J       Date:  2009-04

Review 3.  Comprehensive review on endonasal endoscopic sinus surgery.

Authors:  Rainer K Weber; Werner Hosemann
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2015-12-22

4.  [Inflammatory diseases of the paranasal sinuses: orbital and periorbital complications].

Authors:  W Flügel
Journal:  HNO       Date:  2010-01       Impact factor: 1.284

5.  Management of orbital complications due to rhinosinusitis.

Authors:  V Siedek; A Kremer; C S Betz; U Tschiesner; A Berghaus; A Leunig
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-05-13       Impact factor: 2.503

6.  Trend of surgery for orbital cellulitis: An analysis of state inpatient databases.

Authors:  Pawina Jiramongkolchai; Daniel P Lander; Dorina Kallogjeri; Margaret A Olsen; Matthew Keller; John S Schneider; Jake J Lee; Kim Jiramongkolchai; Jay F Piccirillo
Journal:  Laryngoscope       Date:  2019-05-03       Impact factor: 3.325

7.  Paranasal sinus infection causing orbital subperiosteal abscess: surgical management of this devastating entity.

Authors:  Willian Morais De Melo; Celso Koogi Sonoda; Eduardo Hochuli-Vieira; Marisa Aparecida Cabrini Gabrielli; Mario Francisco Real Gabrielli
Journal:  Oral Maxillofac Surg       Date:  2012-07-31

8.  Management of preseptal and orbital cellulitis.

Authors:  Seongmu Lee; Michael T Yen
Journal:  Saudi J Ophthalmol       Date:  2010-12-10

9.  Radiographic Findings and Clinical Correlates in Pediatric Periorbital Infections.

Authors:  Jonathan M Grischkan; Charles A Elmaraghy; Matthew R Garrett; Boris Karanfilov; Kris R Jatana
Journal:  Int J Otorhinolaryngol       Date:  2015-01

10.  Presentation and management of pediatric orbital cellulitis.

Authors:  Sergio Fanella; Alex Singer; Joanne Embree
Journal:  Can J Infect Dis Med Microbiol       Date:  2011       Impact factor: 2.471

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.